PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Si-M/\'Der Simulierte Mensch,\' a Science Framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.\', \'JPT Peptide Technologies GmbH, Berlin, Germany.\', \'Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.\', \'Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Medical Biotechnology, Institute for Biotechnology, Technische Universität Berlin, Berlin, Germany.\', \'Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Therapy-Induced Remodeling in Immuno-Oncology, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.\', \'Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany.\', \'Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, and Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Clinical Neuroimmunology, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'German Center for Lung Research, Associated Partner, Berlin, Germany.\', \'Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.\', \'Institute for Virology, Universitätsklinikum Essen, Essen, Germany.\', \'Institute for Transfusion Medicine, Tissue Typing Laboratory, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Max Planck Institute for Molecular Genetics, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abh1823
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 34465633
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34465633>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34465633>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all